Works by Smit, Egbert F.
Results: 129
Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 6, p. 442, doi. 10.1093/jnci/djk093
- By:
- Publication type:
- Article
Critical Review of Nonsurgical Treatment Options for Stage I Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2008, v. 13, n. 3, p. 309, doi. 10.1634/theoncologist.2007-0195
- By:
- Publication type:
- Article
Design of Clinical Trials of Radiation Combined with Antiangiogenic Therapy.
- Published in:
- Oncologist, 2007, v. 12, n. 4, p. 465, doi. 10.1634/theoncologist.12-4-465
- By:
- Publication type:
- Article
Cost effectiveness of treatment with new agents in advanced non-small-cell lung cancer: a systematic review.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Cost Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 1, p. 17, doi. 10.2165/11595000-000000000-00000
- By:
- Publication type:
- Article
Elevated hTERT mRNA levels: A potential determinant of bronchial squamous cell carcinoma (in situ).
- Published in:
- International Journal of Cancer, 2004, v. 109, n. 3, p. 412, doi. 10.1002/ijc.11732
- By:
- Publication type:
- Article
Correction: Clonality analysis of pulmonary tumors by genome-wide copy number profiling.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Clonality analysis of pulmonary tumors by genome-wide copy number profiling.
- Published in:
- PLoS ONE, 2019, v. 14, n. 10, p. 1, doi. 10.1371/journal.pone.0223827
- By:
- Publication type:
- Article
Scheduling of anticancer drugs.
- Published in:
- Cell Cycle, 2012, v. 11, n. 23, p. 4339, doi. 10.4161/cc.22187
- By:
- Publication type:
- Article
Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Methodological considerations in quantification of 3'-deoxy-3'-[18F]fluorothymidine uptake measured with positron emission tomography in patients with non-small cell lung cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer.
- Published in:
- Journal of Extracellular Vesicles, 2014, v. 3, p. 1, doi. 10.3402/jev.v3.25657
- By:
- Publication type:
- Article
Therapeutic approach to treating patients with BRAF-mutant lung cancer: latest evidence and clinical implications.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 1, p. 46, doi. 10.1177/1758834016670555
- By:
- Publication type:
- Article
Review: Angiogenesis inhibitors in the treatment of non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2009, v. 1, n. 2, p. 95, doi. 10.1177/1758834009338633
- By:
- Publication type:
- Article
Characteristics of Interstitial Fibrosis and Inflammatory Cell Infiltration in Right Ventricles of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
- Published in:
- International Journal of Rheumatology, 2010, v. 2010, p. 1, doi. 10.1155/2010/604615
- By:
- Publication type:
- Article
Identification of protein biomarkers for prediction of response to platinum‐based treatment regimens in patients with non‐small cell lung cancer.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 6, p. 1417, doi. 10.1002/1878-0261.13555
- By:
- Publication type:
- Article
A genome-wide si RNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 5, p. 534, doi. 10.1002/1878-0261.12052
- By:
- Publication type:
- Article
Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 8, p. 1747, doi. 10.1016/j.molonc.2014.07.008
- By:
- Publication type:
- Article
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 2, p. 212, doi. 10.1038/s41416-024-02709-4
- By:
- Publication type:
- Article
Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment.
- Published in:
- British Journal of Cancer, 2018, v. 119, n. 5, p. 558, doi. 10.1038/s41416-018-0194-7
- By:
- Publication type:
- Article
Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment.
- Published in:
- 2018
- By:
- Publication type:
- journal article
BRAF<sup>V600E</sup>-mutant metastatic NSCLC: disease overview and treatment landscape.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00552-7
- By:
- Publication type:
- Article
Author Correction: BRAF<sup>V600E</sup>-mutant metastatic NSCLC: disease overview and treatment landscape.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
BRAF<sup>V600E</sup>-mutant metastatic NSCLC: disease overview and treatment landscape.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00552-7
- By:
- Publication type:
- Article
BRAF<sup>V600E</sup>-mutant metastatic NSCLC: disease overview and treatment landscape.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00552-7
- By:
- Publication type:
- Article
Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment Patterns and Differences in Survival of Non-Small Cell Lung Cancer Patients Between Academic and Non-Academic Hospitals in the Netherlands.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Rationale and Study Design of the IRENE-Trial (NVALT-16): A Phase II Trial to Evaluate Iressa Rechallenge in Advanced NSCLC Patients With an Activating EGFR Mutation Who Responded to an EGFR-TKI Used As First-Line or Previous Treatment.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 1, p. 60, doi. 10.1016/j.cllc.2014.07.008
- By:
- Publication type:
- Article
Second-line therapy for NSCLC in clinical practice: baseline results of the European SELECTTION observational study.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Reduction in Thyroid Perfusion After Bevacizumab Treatment.
- Published in:
- Thyroid, 2013, v. 23, n. 10, p. 1329, doi. 10.1089/thy.2013.0147
- By:
- Publication type:
- Article
Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancer.
- Published in:
- Proteomics - Clinical Applications, 2016, v. 10, n. 7, p. 743, doi. 10.1002/prca.201600025
- By:
- Publication type:
- Article
Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer.
- Published in:
- PLoS ONE, 2024, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0293707
- By:
- Publication type:
- Article
Time for reappraisal of extracranial treatment options?
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 3, p. 597, doi. 10.1002/cncr.25416
- By:
- Publication type:
- Article
Effects of tracer uptake time in non-small cell lung cancer <sup>18</sup>F-FDG PET radiomics.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262660
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-small- cell lung cancer . .
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
First-in-human study of<sup> 89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [<sup>18</sup>F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [ <sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [<sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article